company background image
A065660 logo

Anterogen.Co.Ltd KOSDAQ:A065660 Stock Report

Last Price

₩15.00k

Market Cap

₩146.0b

7D

7.1%

1Y

12.9%

Updated

13 Oct, 2024

Data

Company Financials

Anterogen.Co.,Ltd.

KOSDAQ:A065660 Stock Report

Market Cap: ₩146.0b

A065660 Stock Overview

A bio-venture company, engages in the research, development, and commercialization of cell therapy products using adipose-derived stem cells in South Korea and internationally.

A065660 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Anterogen.Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Anterogen.Co.Ltd
Historical stock prices
Current Share Price₩15,000.00
52 Week High₩19,150.00
52 Week Low₩12,300.00
Beta0.34
11 Month Change6.38%
3 Month Change-4.58%
1 Year Change12.87%
33 Year Change-79.17%
5 Year Change-62.73%
Change since IPO-61.64%

Recent News & Updates

Does Anterogen.Co.Ltd (KOSDAQ:065660) Have A Healthy Balance Sheet?

Apr 04
Does Anterogen.Co.Ltd (KOSDAQ:065660) Have A Healthy Balance Sheet?

Recent updates

Does Anterogen.Co.Ltd (KOSDAQ:065660) Have A Healthy Balance Sheet?

Apr 04
Does Anterogen.Co.Ltd (KOSDAQ:065660) Have A Healthy Balance Sheet?

Health Check: How Prudently Does Anterogen.Co.Ltd (KOSDAQ:065660) Use Debt?

Feb 05
Health Check: How Prudently Does Anterogen.Co.Ltd (KOSDAQ:065660) Use Debt?

Does Anterogen.Co.Ltd's (KOSDAQ:065660) Share Price Gain of 25% Match Its Business Performance?

Dec 14
Does Anterogen.Co.Ltd's (KOSDAQ:065660) Share Price Gain of 25% Match Its Business Performance?

Shareholder Returns

A065660KR BiotechsKR Market
7D7.1%4.0%0.9%
1Y12.9%49.5%3.8%

Return vs Industry: A065660 underperformed the KR Biotechs industry which returned 49.5% over the past year.

Return vs Market: A065660 exceeded the KR Market which returned 3.8% over the past year.

Price Volatility

Is A065660's price volatile compared to industry and market?
A065660 volatility
A065660 Average Weekly Movement5.9%
Biotechs Industry Average Movement8.8%
Market Average Movement6.8%
10% most volatile stocks in KR Market12.2%
10% least volatile stocks in KR Market3.6%

Stable Share Price: A065660 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A065660's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2000n/aSeong-Gu Leeanterogen.com

Anterogen Co.,Ltd., a bio-venture company, engages in the research, development, and commercialization of cell therapy products using adipose-derived stem cells in South Korea and internationally. The company offers medicines, including Cupistem injection, an adipose stem cell product that is used for the treatment of Crohn’s fistula; Queencell, a stromal vascular fraction used for the regeneration of subcutaneous adipose tissue; and Remodulin injection, a medicine for the treatment of pulmonary arterial hypertension.

Anterogen.Co.,Ltd. Fundamentals Summary

How do Anterogen.Co.Ltd's earnings and revenue compare to its market cap?
A065660 fundamental statistics
Market cap₩145.97b
Earnings (TTM)-₩2.31b
Revenue (TTM)₩6.66b

21.9x

P/S Ratio

-63.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A065660 income statement (TTM)
Revenue₩6.66b
Cost of Revenue₩3.92b
Gross Profit₩2.74b
Other Expenses₩5.06b
Earnings-₩2.31b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-237.78
Gross Margin41.18%
Net Profit Margin-34.75%
Debt/Equity Ratio0%

How did A065660 perform over the long term?

See historical performance and comparison